What is it about?

A review of the major trials that studied the use of Tocilizumab in the treatment of COVID-19. We highlight the strengths and limitations of each trial and the conclusions drawn from the evidence.

Featured Image

Why is it important?

The results obtained by a study is only as significant as the quality of the study. It is very important to be able to critically appraise a study before relying on its conclusions.


These trials showed how relatively safe Tocilizumab is and how it is efficient in the treatment of COVID-19 in combination with steroids. The trials that showed this benefit were using steroids as part of their treatment regimen after they had been shown to decrease mortality. This was a great way to delve deep into statistics and critical analysis of different studies.

Dr. Walid Alam
Maidstone and Tunbridge Wells NHS Trust

Read the Original

This page is a summary of: Efficacy of tocilizumab in COVID-19: A review of the current evidence, Science Progress, July 2021, SAGE Publications,
DOI: 10.1177/00368504211030372.
You can read the full text:



The following have contributed to this page